Body composition in women with sickle cell disease

Ethnicity and Disease

Volumn 11, Issue 1, 2001, Pages 30-35

  Woods, K F ^a,b   Ramsey, L T ^a   Callahan, L A ^a   Mensah, G A ^a   Litaker, M S ^a   Kutlar, A ^a   Barbeau, P ^a   Gutin, B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Body composition; Bone density; Health status; Obesity; Sickle cell anemia; Sickle cell disease

Indexed keywords

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; FEMALE; HEALTH STATUS; HUMAN; PATHOPHYSIOLOGY; RADIODENSITOMETRY; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HEALTH STATUS; HUMANS;

EID: 0035650430     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Vichinsky E. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Sem Hematol. 1991;28(3):220-226.
2. Lieken SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84: 500-508.
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330: 1639-1644.
4. Stewart Al, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results of the Medical Outcomes Study. JAMA 1989;262:907-913.
5. Woods K, Lambert C, Miller M, et al. Health status in adults with sickle cell disease. JCOM. 1997; 4(5): 15-21.
6. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Centers for Chronic Disease Prevention and Health Promotion; 1996.
7. Platt OS, Rosenstock W, Espeland E. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med. 1984;311:7-12.
8. Gee BE, Platt OS. Growth and development. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:589-597.
9. Phebus CK, Gloninger MR, Maciak BJ. Growth patterns by age and sex in children with sickle cell disease. J Pediatr. 1984;105:28-33.
10. Mann JR. Sickle cell hemoglobinopathies in England. Arch Dis Child. 1981;56:676-683.
11. Blair SN, Piscerchia PV, Wilbur CS, Crowder JH. A public health intervention model for work-site health promotion. Impact on exercise and physical fitness in a health promotion plan after 24 months. JAMA. 1986;255(7):921-926.
12. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985;121(1):91-106.
13. Lohman T. Dual energy x-ray absorptiometry. In: Human Body Composition. Champaign, Ill: Human Kinetics; 1996.
14. Gutin B, Litaker M, Islam S, Manos T, Smith C, Treiber F. Body composition measurements in 9-11 y-old children by dual-energy x-ray absorptiometry, skinfold-thickness measurements, and bioimpedance analysis. Am J Clin Nutr. 1996;63: 287-292.
15. Kohrt W. Body Composition By DXA: tried and true? Med Sci Sports Exerc. 1995;27:1349-1353.
16. Winsor T, Burch GE. The habitus of patients with sickle cell anemia. Hum Biol. 1944;6:99-114.
17. Ashcroft M, Serjeant G, et al. Heights, weights and skeletal age of Jamaican adolescents with sickle cell anemia. Arch Dis Child. 1972;47:519-524.
18. Luban NLC, Leiken SL, et al. Growth and development in sickle cell anemia: preliminary report. Am J Pediatr Hematol Oncol. 1982;4:61-65.
19. Stevens MCG, Maude GH, et al. Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics. 1986;78:124-132.
20. Oyedeji GA. The health, growth, and educational performance of sickle cell disease in children. East Afr Med J. 1991;68:181-189.
21. Salmon EK, Haymond MW, Bayne E, et al. Protein metabolism and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996;40(1):34-40.
22. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease [see comments]. Am J Clin Nutr. 1993;57:32-34.
23. Badaloo A, Jackson AA, Jahoor F. Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci. 1989;77: 93-97.
24. Flakoll PJ, Myfanwy JB, Buchowski MS, et al. Sickle cell disease patients have anomalies in whole-body protein metabolism that increase energy expenditure. Proc Natl Sickle Cell Dis Programs Meeting. 1997:187.
25. Singhal A, Morris J, Thomas P, Dover G, Higgs D, Serjeant G. Factors influencing prepubertal growth in homozygous sickle cell disease. Arch Dis Child 1996;74;502-506.
26. Hackney AC, Heizer W, Hoffman E, Jones S, Strayhorn D, Orringer EP. Effects of hydroxyurea (HU) administration on body weight, body composition, and exercise performance of patients with sickle cell anemia. Clin Sci. 1997;92(5):481-486.
27. Williams R, Wynn L, Dancy R, et al. Resting energy expenditure in patients with sickle cell disease treated with hydroxyurea. Proc Natl Sickle Cell Dis Programs Meeting. 1997:340.
28. Williams R, Wang W. Nutritional assessment in children with sickle cell disease. Proc Natl Sickle Cell Dis Programs Meeting. 1997:339.
29. Kopp-Hoolihan LE, Van Loan MD, Mentzer WC, Heyman MB. Elevated resting energy expenditure in adolescents with sickle cell anemia. J Am Diet Assoc. 1999;99(2):195-199.
30. Reid IA, Ames R, Evans MC, et al. Determinants of total body and regional bone mineral density in normal postmenopausal women: a key role for fat mass. J Clin Endocrinol Metab. 1992;75(1):45-51.
31. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr. 1998;132:467-471.
32. Kawchak DA, Zemel BS, Ohenu-Frempong K, Stallings VA. Bone density and calcium intake in children with SCD. Proc Natl Sickle Cell Dis Programs Meeting. 1997:133.
33. Finklestien JS, Neer RM, Biller BMK, Crowford JD, Kilbanski A. Osteopenia in adult men with histories of delayed puberty. N Eng J Med. 1992; 326:600-604.
34. Soliman AT, Bererhi H, Darwish A, Alzalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr. 1998;44:194-198.
35. Steiner RM, Mitchell DG, Rao VM, et al. Magnetic resonance imaging of bone marrow: diagnostic value in diffuse hematologic disorders. Magn Reson Q. 1990;6(1):17-34.
36. Milner PF, Joe C, Burke GJ. Bone and joint disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:645-661.
37. Mohammed SM, Suleiman SA, et al. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease. Clin Chim Acta. 1991;203:285-294.